Julia Stingl
Impact in
- Oncology top 0.2%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 58
- Cancer Cells and Metastasis 32
- Drug Transport and Resistance Mechanisms 8
- Colorectal Cancer Treatments and Studies 7
- Pharmacology 52
- Pharmacogenetics and Drug Metabolism 52
- Co-authors
- Connie J. Eaves (14 shared papers)Jane E. Visvader (5 shared papers)François Vaillant (4 shared papers)Mark Shackleton (4 shared papers)Carlos Caldas (8 shared papers)Joanne T. Emerman (10 shared papers)Peter Eirew (6 shared papers)Geoffrey J. Lindeman (4 shared papers)
- Journals
- Pharmacogenomics (12 papers)PLoS ONE (9 papers)British Journal of Clinical Pharmacology (9 papers)Clinical Pharmacology & Therapeutics (8 papers)Breast Cancer Research (8 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Julia Stingl
208 papers receiving 12.3k citations
Julia Stingl's Hit Papers
Peers
Comparison fields: 5 of 159
- Oncology 5.4k
- Pharmacology 1.8k
- Cancer Research 1.7k
- Biological Psychiatry 214
- Molecular Biology 4.8k
Countries citing papers authored by Julia Stingl
This map shows the geographic impact of Julia Stingl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Stingl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Stingl more than expected).
Fields of papers citing papers by Julia Stingl
This network shows the impact of papers produced by Julia Stingl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Stingl. The network helps show where Julia Stingl may publish in the future.
Co-authors
The 25 scholars most cited alongside Julia Stingl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 220 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Generation of a functional mammary gland from a single stem cell Hit paper breakdown → | 2006 | 1611 |
| 2 | Purification and unique properties of mammary epithelial stem cells Hit paper breakdown → | 2006 | 1265 |
| 3 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors Hit paper breakdown → | 2015 | 713 |
| 4 | Progesterone induces adult mammary stem cell expansion Hit paper breakdown → | 2010 | 526 |
| 5 | Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update Hit paper breakdown → | 2016 | 481 |
| 6 | Mammary stem cells and the differentiation hierarchy: current status and perspectives Hit paper breakdown → | 2014 | 409 |
| 7 | 2007 | 383 | |
| 8 | Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants Hit paper breakdown → | 2013 | 352 |
| 9 | 2015 | 332 | |
| 10 | 2001 | 294 | |
| 11 | 2008 | 276 | |
| 12 | 2013 | 276 | |
| 13 | 2008 | 258 | |
| 14 | 2006 | 236 | |
| 15 | 2012 | 231 | |
| 16 | 1998 | 203 | |
| 17 | 2014 | 176 | |
| 18 | 2013 | 167 | |
| 19 | 2013 | 148 | |
| 20 | 2012 | 133 |
About Julia Stingl
Julia Stingl is a scholar working on Oncology, Pharmacology, Molecular Biology, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 220 papers that have together received 12.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (52 papers), Cancer Cells and Metastasis (32 papers), Pharmaceutical studies and practices (14 papers), Pharmacovigilance and Adverse Drug Reactions (13 papers), Drug Transport and Resistance Mechanisms (8 papers), Tea Polyphenols and Effects (8 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). The work is most often cited by research in Oncology (5.4k citations), Pharmacology (1.8k citations), Cancer Research (1.7k citations), Biological Psychiatry (214 citations) and Molecular Biology (4.8k citations). Julia Stingl has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Connie J. Eaves, Jane E. Visvader, François Vaillant, Mark Shackleton, Carlos Caldas, Joanne T. Emerman, Peter Eirew, Geoffrey J. Lindeman, Marie-Liesse Asselin-Labat and Kaylene J. Simpson. Their work appears in journals such as Pharmacogenomics, PLoS ONE, British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.